Cargando…
Macrophage Activities in Myocardial Infarction and Heart Failure
Heart diseases remain the major cause of death worldwide. Advances in pharmacological and biomedical management have resulted in an increasing proportion of patients surviving acute heart failure (HF). However, many survivors of HF in the early stages end up increasing the disease to chronic HF (CHF...
Autores principales: | Duncan, Sophia Esi, Gao, Shan, Sarhene, Michael, Coffie, Joel Wake, Linhua, Deng, Bao, Xingru, Jing, Zhang, Li, Sheng, Guo, Rui, Su, Jing, Fan, Guanwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193281/ https://www.ncbi.nlm.nih.gov/pubmed/32377427 http://dx.doi.org/10.1155/2020/4375127 |
Ejemplares similares
-
Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases
por: Guo, Rui, et al.
Publicado: (2020) -
Influence of heart failure on the prognosis of patients with acute myocardial infarction in southwestern China
por: DENG, FUXUE, et al.
Publicado: (2016) -
The protective effects of different compatibility proportions of the couplet medicines for Astragali Radix and Angelica sinensis Radix on myocardial infarction injury
por: Chen, Lu, et al.
Publicado: (2020) -
Cushing's syndrome presenting as non‐atherosclerotic myocardial infarction and heart failure
por: Li, Yanming, et al.
Publicado: (2023) -
Alamandine alleviated heart failure and fibrosis in myocardial infarction mice
por: Zhao, Kun, et al.
Publicado: (2022)